AI in BD&L: Practical Tips for In-Licensing, Out-Licensing & Deal Execution


AI is beginning to find its place in BD&L. While adoption varies across companies, many BD teams are already experimenting with AI to speed up search, landscape monitoring and early-stage analysis. Yet questions remain about where AI truly adds value and where traditional methods still outperform the technology.

Watch this 45-minute recorded webinar (10 February 2026) with CELforPharma faculty member Dr Carlos Velez.

Continue your learning from Dr Carlos Velez

If you’d like to learn more from Dr Carlos Velez, CELforPharma also offers a 2-day, hands-on course where you will:

  • Gain a clear end-to-end view of BD&L in pharma and biotech
  • Understand in-licensing and out-licensing planning and execution
  • Learn the basics of valuation, IP, term sheets, and negotiation
  • Work through case studies and group exercises grounded in real practice

Don’t miss future CELforPharma webinars

Subscribe to our newsletter to:

  • Receive invitations to upcoming educational webinars
  • Stay on top of the latest expert insights
  • Get updates on our courses and training programmes